Collplant biotechnologies provides business updates and fiscal year 2021 financial results

Rehovot, israel, march 24, 2022 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced business updates and financial results for the fiscal year ended december 31, 2021. "2021 was a highly productive and transformative year for collplant's r&d and business development activities.
CLGN Ratings Summary
CLGN Quant Ranking